Transversus Abdominis Plane Block and Quadratus Lumborum Block in Pediatric Patients

Sponsor

Bakirkoy Dr. Sadi Konuk Research and Training Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT04209478

Collaborator

(none)

Enrollment

Location

Arms

Actual Duration (Months)

5.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In the pediatric age group, postoperative pain is very important for the children to have a comfortable and problem-free postoperative period.

In the present study, it was aimed to compare the postoperative analgesic efficacy of Transversus abdominis plane (TAP) Block, and quadratus lumborum block (QLB) Type 1 on the pediatric patients

Condition or Disease	Intervention/Treatment	Phase
Pain, Postoperative	Drug: Tramadol hydrochloride	N/A

Detailed Description

Patients included in the study were randomly divided into 2 groups. Cases were assessed ultrasonography-guided TAP block (Group B, n=20) or ultrasonography-guided QL Block. Total analgesic amounts in 24 hours and first analgesic requirement times recorded.

Study Design

Study Type:

Interventional

Actual Enrollment :

40 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Double (Participant, Investigator)

Primary Purpose:

Other

Official Title:

Transversus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Pediatric Patients; a Prospective, Randomized, Controlled Study

Actual Study Start Date :

May 1, 2016

Actual Primary Completion Date :

Nov 30, 2016

Actual Study Completion Date :

Nov 30, 2016

Arms and Interventions

Arm	Intervention/Treatment
Experimental: TAP Block Cases were assessed transversus abdominis plane block for postoperative analgesia	Drug: Tramadol hydrochloride The Wong-Baker facial pain scale was used to assess pain (1: no pain, 10: worst possible pain). During monitoring patients with pain score ≥3 had intravenous 1 mg/kg tramadol hydrochloride administered, After 15 minutes following tramadol injection, cases with pain score continuing ≥3 were to be assessed as insufficient analgesia and had 0.1 mg/kg morphine hydrochloride planned for intravenous administration Other Names: morphine hydrochloride
Experimental: QL Block Cases were assessed quadratus lumborum block for postoperative analgesia	Drug: Tramadol hydrochloride The Wong-Baker facial pain scale was used to assess pain (1: no pain, 10: worst possible pain). During monitoring patients with pain score ≥3 had intravenous 1 mg/kg tramadol hydrochloride administered, After 15 minutes following tramadol injection, cases with pain score continuing ≥3 were to be assessed as insufficient analgesia and had 0.1 mg/kg morphine hydrochloride planned for intravenous administration Other Names: morphine hydrochloride

Arm

Intervention/Treatment

Experimental: TAP Block

Cases were assessed transversus abdominis plane block for postoperative analgesia

Drug: Tramadol hydrochloride

The Wong-Baker facial pain scale was used to assess pain (1: no pain, 10: worst possible pain). During monitoring patients with pain score ≥3 had intravenous 1 mg/kg tramadol hydrochloride administered, After 15 minutes following tramadol injection, cases with pain score continuing ≥3 were to be assessed as insufficient analgesia and had 0.1 mg/kg morphine hydrochloride planned for intravenous administration

Other Names:

morphine hydrochloride

Experimental: QL Block

Cases were assessed quadratus lumborum block for postoperative analgesia

Drug: Tramadol hydrochloride

Other Names:

morphine hydrochloride

Outcome Measures

Primary Outcome Measures

the analgesic use of the groups in 24 hours [how many times in 24 hours]
the number of analgesic requirements

Eligibility Criteria

Criteria

Ages Eligible for Study:

3 Years to 16 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

The study included 40 cases undergoing lower abdominal surgery aged from 3 to 16 years with American Society of Anesthesiologist I-II level.

Exclusion Criteria:

Cases with American Society of Anesthesiologist III-IV health level and those with a history of allergy to local anesthetic medications were not included in the study